Stereoselective Synthesis of New (2S,3R)-3-Carboxyphenyl)pyrrolidine-2-carboxylic Acid Analogues Utilizing a C(sp3)-H Activation Strategy and Structure-Activity Relationship Studies at the Ionotropic Glutamate Receptors. 2020

Silke Kayser, and Jacob C Hansen, and Markus Staudt, and Aleksandra Moroz, and Younes Larsen, and Piero Temperini, and Feng Yi, and Jed T Syrenne, and Niels Krogsgaard-Larsen, and Stylianos Iliadis, and Birgitte Nielsen, and Kasper B Hansen, and Darryl S Pickering, and Lennart Bunch
Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen 2100, Denmark.

Competitive antagonists for ionotropic glutamate receptors (iGluRs) are highly valuable tool compounds for studying health and disease states in the central nervous system. However, only few subtype selective tool compounds are available and the discovery of antagonists with novel iGluR subtype selectivity profiles remains a profound challenge. In this paper, we report an elaborate structure-activity relationship (SAR) study of the parental scaffold 2,3-trans-3-carboxy-3-phenyl-proline by the synthesis of 40 new analogues. Three synthetic strategies were employed with two new strategies of which one being a highly efficient and fully enantioselective strategy based on C(sp3)-H activation methodology. The SAR study led to the conclusion that selectivity for the NMDA receptors was a general trend when adding substituents in the 5'-position. Selective NMDA receptor antagonists were obtained with high potency (IC50 values as low as 200 nM) and 3-34-fold preference for GluN1/GluN2A over GluN1/GluN2B-D NMDA receptors.

UI MeSH Term Description Entries
D011392 Proline A non-essential amino acid that is synthesized from GLUTAMIC ACID. It is an essential component of COLLAGEN and is important for proper functioning of joints and tendons. L-Proline,L Proline
D011759 Pyrrolidines Compounds also known as tetrahydropyridines with general molecular formula (CH2)4NH. Tetrahydropyridine,Tetrahydropyridines
D002264 Carboxylic Acids Organic compounds containing the carboxy group (-COOH). This group of compounds includes amino acids and fatty acids. Carboxylic acids can be saturated, unsaturated, or aromatic. Carboxylic Acid,Acid, Carboxylic,Acids, Carboxylic
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D016194 Receptors, N-Methyl-D-Aspartate A class of ionotropic glutamate receptors characterized by affinity for N-methyl-D-aspartate. NMDA receptors have an allosteric binding site for glycine which must be occupied for the channel to open efficiently and a site within the channel itself to which magnesium ions bind in a voltage-dependent manner. The positive voltage dependence of channel conductance and the high permeability of the conducting channel to calcium ions (as well as to monovalent cations) are important in excitotoxicity and neuronal plasticity. N-Methyl-D-Aspartate Receptor,N-Methyl-D-Aspartate Receptors,NMDA Receptor,NMDA Receptor-Ionophore Complex,NMDA Receptors,Receptors, NMDA,N-Methylaspartate Receptors,Receptors, N-Methylaspartate,N Methyl D Aspartate Receptor,N Methyl D Aspartate Receptors,N Methylaspartate Receptors,NMDA Receptor Ionophore Complex,Receptor, N-Methyl-D-Aspartate,Receptor, NMDA,Receptors, N Methyl D Aspartate,Receptors, N Methylaspartate
D058468 Receptors, Ionotropic Glutamate A class of ligand-gated ion channel receptors that have specificity for GLUTAMATE. They are distinct from METABOTROPIC GLUTAMATE RECEPTORS which act through a G-protein-coupled mechanism. Ionotropic Glutamate Receptor,Ionotropic Glutamate Receptors,Glutamate Receptor, Ionotropic,Glutamate Receptors, Ionotropic,Receptor, Ionotropic Glutamate

Related Publications

Silke Kayser, and Jacob C Hansen, and Markus Staudt, and Aleksandra Moroz, and Younes Larsen, and Piero Temperini, and Feng Yi, and Jed T Syrenne, and Niels Krogsgaard-Larsen, and Stylianos Iliadis, and Birgitte Nielsen, and Kasper B Hansen, and Darryl S Pickering, and Lennart Bunch
August 2015, Journal of medicinal chemistry,
Silke Kayser, and Jacob C Hansen, and Markus Staudt, and Aleksandra Moroz, and Younes Larsen, and Piero Temperini, and Feng Yi, and Jed T Syrenne, and Niels Krogsgaard-Larsen, and Stylianos Iliadis, and Birgitte Nielsen, and Kasper B Hansen, and Darryl S Pickering, and Lennart Bunch
February 2011, ACS chemical neuroscience,
Silke Kayser, and Jacob C Hansen, and Markus Staudt, and Aleksandra Moroz, and Younes Larsen, and Piero Temperini, and Feng Yi, and Jed T Syrenne, and Niels Krogsgaard-Larsen, and Stylianos Iliadis, and Birgitte Nielsen, and Kasper B Hansen, and Darryl S Pickering, and Lennart Bunch
February 2013, Journal of medicinal chemistry,
Silke Kayser, and Jacob C Hansen, and Markus Staudt, and Aleksandra Moroz, and Younes Larsen, and Piero Temperini, and Feng Yi, and Jed T Syrenne, and Niels Krogsgaard-Larsen, and Stylianos Iliadis, and Birgitte Nielsen, and Kasper B Hansen, and Darryl S Pickering, and Lennart Bunch
February 2017, Bioorganic & medicinal chemistry letters,
Silke Kayser, and Jacob C Hansen, and Markus Staudt, and Aleksandra Moroz, and Younes Larsen, and Piero Temperini, and Feng Yi, and Jed T Syrenne, and Niels Krogsgaard-Larsen, and Stylianos Iliadis, and Birgitte Nielsen, and Kasper B Hansen, and Darryl S Pickering, and Lennart Bunch
November 2014, The Journal of organic chemistry,
Silke Kayser, and Jacob C Hansen, and Markus Staudt, and Aleksandra Moroz, and Younes Larsen, and Piero Temperini, and Feng Yi, and Jed T Syrenne, and Niels Krogsgaard-Larsen, and Stylianos Iliadis, and Birgitte Nielsen, and Kasper B Hansen, and Darryl S Pickering, and Lennart Bunch
March 2024, Organic & biomolecular chemistry,
Silke Kayser, and Jacob C Hansen, and Markus Staudt, and Aleksandra Moroz, and Younes Larsen, and Piero Temperini, and Feng Yi, and Jed T Syrenne, and Niels Krogsgaard-Larsen, and Stylianos Iliadis, and Birgitte Nielsen, and Kasper B Hansen, and Darryl S Pickering, and Lennart Bunch
December 1971, Arzneimittel-Forschung,
Silke Kayser, and Jacob C Hansen, and Markus Staudt, and Aleksandra Moroz, and Younes Larsen, and Piero Temperini, and Feng Yi, and Jed T Syrenne, and Niels Krogsgaard-Larsen, and Stylianos Iliadis, and Birgitte Nielsen, and Kasper B Hansen, and Darryl S Pickering, and Lennart Bunch
February 2013, Journal of medicinal chemistry,
Silke Kayser, and Jacob C Hansen, and Markus Staudt, and Aleksandra Moroz, and Younes Larsen, and Piero Temperini, and Feng Yi, and Jed T Syrenne, and Niels Krogsgaard-Larsen, and Stylianos Iliadis, and Birgitte Nielsen, and Kasper B Hansen, and Darryl S Pickering, and Lennart Bunch
July 2012, Bioorganic & medicinal chemistry letters,
Silke Kayser, and Jacob C Hansen, and Markus Staudt, and Aleksandra Moroz, and Younes Larsen, and Piero Temperini, and Feng Yi, and Jed T Syrenne, and Niels Krogsgaard-Larsen, and Stylianos Iliadis, and Birgitte Nielsen, and Kasper B Hansen, and Darryl S Pickering, and Lennart Bunch
January 2017, Journal of medicinal chemistry,
Copied contents to your clipboard!